Markets.News
The ALS Association has recently announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards Program in Arlington, Virginia on December 4th. This funding, intended to hasten the advancement of new treatments for ALS, was granted to several individuals. The specific amount awarded was not disclosed, but it is part of the Association's ongoing efforts to support innovative research in ALS treatment.